Cardiac amyloidosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(36 intermediate revisions by 8 users not shown)
Line 1: Line 1:
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
__NOTOC__
 
{{Infobox_Disease |
{{Infobox_Disease |
   Name          = {{PAGENAME}} |
   Name          = {{PAGENAME}} |
   Image          = LA Amyloid.jpg|
   Image          = LA Amyloid.jpg|
   Caption        = Amyloidosis Lesion In Left Atrium: Gross natural color view of a diagnostic lesion <br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>|
   Caption        = Amyloidosis Lesion In Left Atrium: Gross natural color view of a diagnostic lesion <br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>|
  DiseasesDB    = |
  ICD10          = |
  ICD9          = {{ICD9|277.3}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID        = |
}}
}}
'''For patient information click [[{{PAGENAME}} (patient information)|here.]]'''<br>
'''To go back to the Amyloidosis landing page, click [[Amyloidosis|here]].'''<br>
{{Cardiac amyloidosis}}
{{CMG}}; {{AE}} {{AN}} {{RT}}; {{CZ}}; {{LG}}, {{Sab}}


{{SI}}
{{SK}} Cardiac amyloid; amyloid cardiac; amyloid cardiomyopathy; stiff heart syndrome; senile cardiac amyloidosis; AS transthyretin amyloidosis; amyloid heart muscle disease; amyloid heart disease; amyloid heart; CA
{{CMG}}; '''Associate Editor:''' {{CZ}}
 
==Overview==
 
'''Cardiac amyloidosis''' is a well-known condition, which has been reported with varying incidence rates. Myocardial involvement results in severe dysfunction and is the leading cause of death in patients with amyloidosis. Systemic amyloidosis of AL and TTR type is often associated with amyloid deposition in heart valves, in addition to blood vessels and myocardium <ref>Pomerance, A. The pathology of senile cardiac amyloidosis. J. Pathol. Bacteriol. 91, 357. 1966</ref> <ref>Buja, L. M., Khoi, N. B., and Roberts W. C. Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients. Am. J. Cardiol., 26, 394. 1970</ref> In this classical type of valvular amyloidosis are the deposits occur in previously unaltered valves.
 
There is also another type of cardiac amyloidosis restricted entirely to the heart valves and can be found in valves, surgically removed for chronic valvular disease. The deposits are small and restricted to the areas of scarring and calcification.<ref>Goffin, Y. A. Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring. J. Clin. Pathol., 33, 262. 1980</ref> The amyloid protein has not been identified but it has been demonstrated not to be AL or AA <ref>Goffin, Y. A., Murdoch, W., Cornwell, G. G. III, and Sorenson, G. D. Microdeposits of amyloid in sclerocalcific heart valves: a histochemical and immunoflourescence study. J. Clin. Pathol., 36, 1342. 1983</ref> <ref>Amyloid and amyloidosis. Gilles Grateau, Robert A. Kyle, Martha Skinner, 2005 ISBN 0-8493-3534-5</ref>
 
==Causes==
[[Amyloidosis]] is the buildup of a [[fibril]] called [[amyloid]] in any tissue in the body. Fibrils are proteins produced in excess and slowly deposited where they replace normal tissue.
 
Different types of amyloidosis are caused by different types of proteins, such as "AL" and "AA." In cardiac amyloidosis there may be associated conduction disturbances (changes in the way the cardiac electrical impulse is transmitted through the heart).


Cardiac amyloidosis usually occurs during primary (AL) amyloidosis. Primary amyloidosis usually accompanies multiple [[myeloma]], a blood disorder in which too much of a certain type of protein is produced. This excess protein is deposited in the heart and in other organs such as the [[kidney]]. Deteriorating kidney function also occurs.
==[[Cardiac amyloidosis overview|Overview]]==


The heart is less often compromised by secondary (AA) amyloidosis. A type of secondary amyloidosis that involves the heart is senile amyloidosis. It is caused by overproduction of a protein different from both the AA and AL types. This protein is deposited mainly in the heart, but can also infiltrate blood vessels. Senile cardiac amyloidosis is becoming more common as the average age of the population increases.
==[[Cardiac amyloidosis historical perspective|Historical Perspective]]==


Cardiac amyloidosis is the most typical [[restrictive cardiomyopathy]], and it is also known as “stiff heart syndrome.” Much less frequently, cardiac amyloidosis leads to dilated [[cardiomyopathy]].
==[[Cardiac amyloidosis classification|Classification]]==


Several lines of evidence indicate that the degree of myocardial dysfunction does not depend only on the extent of amyloid deposits but also on the biochemical characteristics of the amyloidogenic proteins which dictate the aggregation process.<ref>Dubrey SW, Cha K, Skinner M, et al (1997). Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart; 78: 74-82.</ref> <ref>Palladini G, Campana C, Clersy C, et al (2003). Serum N-terminal pro Brain Natriuretic Peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation; 107: 2440-45.</ref>
==[[Cardiac amyloidosis pathophysiology|Pathophysiology]]==


Cardiac amyloidosis is more common in men than in women.
==[[Cardiac amyloidosis causes|Causes]]==


==Symptoms==
==[[Cardiac amyloidosis differential diagnosis|Differentiating Cardiac amyloidosis from other Diseases]]==
* [[Palpitation]]s
* [[Rales]]
* [[Peripheral edema]] and [[ascites]]
* [[Nocturia]]
* [[Fatigue]]
* [[Dyspnea]]
* [[Orthopnea]]<ref>Kyle RA, Gertz MA (1995). Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol; 8: 45-59.</ref>


==Signs and tests==
==[[Cardiac amyloidosis epidemiology and demographics|Epidemiology and Demographics]]==


Cardiac amyloidosis is difficult to diagnose. The findings from an examination are not specific and may indicate enlargement of the heart and fluid retention in the lungs. Auscultation may reveal [[rales]], [[heart murmur]]s, and/or other pathologic heart sounds.
==[[Cardiac amyloidosis risk factors|Risk Factors]]==
Hepatomegaly and elevated jugular pressure may occur. The blood pressure may be low or may drop when rising to a standing position ([[orthostatic hypotension]]). Orthostatic hypotension is typical especially in kidney involvement.


Cardiomegaly, congestion of the lungs or the veins in the lungs, decreased movement and/or functioning of the heart, heart failure, or signs of amyloidosis in the heart and other organs may show on the following tests:
==[[Cardiac amyloidosis screening|Screening]]==
* [[Echocardiogram]]
* [[Chest x-ray]]
* Thoracoabdominal [[CT scan]]
* Coronary [[angiography]]
* Nuclear cardiac scans: [[MUGA scan|MUGA]] and Radionuclide ventriculography (RNV)
* [[Magnetic resonance imaging]] (MRI)


The EKG may reveal:
==[[Cardiac amyloidosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
*[[Heart block]]
*AV nodal slowing
*[[Arrhythmia]]s such as
:*[[Atrial fibrillation]]
:*[[Ventricular tachycardia]]
:*[[Premature ventricular contractions]]


An echocardiogram may be used to assess the thickness of the heart wall, the size of the chambers in the heart, and the ability of the heart to fill and pump blood. Sometimes an unusual texture of the heart muscle or the [[endocardium]] (the lining of the heart) can be seen as well.
==Diagnosis==
 
[[Cardiac amyloidosis diagnostic study of choice|Diagnostic study of choice]] | [[Cardiac amyloidosis history and symptoms|History and Symptoms]] | [[Cardiac amyloidosis physical examination|Physical Examination]] | [[Cardiac amyloidosis laboratory findings|Laboratory Findings]] | [[Cardiac amyloidosis electrocardiogram|Electrocardiogram]] | [[Cardiac amyloidosis x ray|X-Ray Findings]] | [[Cardiac amyloidosis echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Cardiac amyloidosis CT scan|CT-Scan Findings]] | [[Cardiac amyloidosis MRI|MRI Findings]] | [[Cardiac amyloidosis other imaging findings|Other Imaging Findings]] | [[Cardiac amyloidosis other diagnostic studies|Other Diagnostic Studies]]
A cardiac [[biopsy]] that reveals [[amyloid]] confirms the diagnosis. Biopsy of other tissues may also confirm the diagnosis. Amyloidosis is frequently confirmed by biopsy of abdominal [[fat]], [[kidney]], or [[bone marrow]].


==Treatment==
==Treatment==
Physical activity may continue as long as the patient can tolerate it. Diet restrictions vary with the extent of [[cardiomyopathy]] and [[heart failure]]. These may include [[salt]] and/or [[fluid]] restrictions.
[[Cardiac amyloidosis medical therapy|Medical Therapy]] | [[Cardiac amyloidosis surgery|Surgery]] | [[Cardiac amyloidosis primary prevention|Primary Prevention]] | [[Cardiac amyloidosis secondary prevention|Secondary Prevention]] | [[Cardiac amyloidosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Cardiac amyloidosis future or investigational therapies|Future or Investigational Therapies]]


[[Diuretic]]s (water pills) may be given to remove excess fluid. [[Digoxin]] may be used cautiously to improve heart control in patients with atrial fibrillation. Daily weight measurement may be recommended. A weight gain of 3 or 4 pounds or more over 1 or 2 days can indicate excessive fluid accumulation.
==Case Studies==
[[Cardiac amyloidosis case study one|Case #1]]


Some people benefit from [[chemotherapy]] or [[prednisone]].
A [[artificial pacemaker|pacemaker]] may be needed if the conduction system is involved. When heart function is very poor, a heart transplant may be considered for some patients, but not those with AL type amyloidosis since their disease compromises many organs. In one type of secondary amyloidosis, [[liver]] transplantation is also required.
==Prognosis==
Cardiac amyloidosis is a chronic and progressive condition.  A cardiologist may estimate the prognosis according to the thickness of the [[left ventricle]] and to the degree of restriction in the heart (diastolic dysfunction). For primary amyloidosis, the median survival after diagnosis is about 2.1 years.
==Complications==
* Congestive [[heart failure]]
* [[Atrial fibrillation]] or [[ventricular arrhythmia]]s
* [[Sick sinus syndrome]] (occasionally)
* Symptomatic cardiac conduction system disease (arrhythmias related to abnormal conduction of impulses through the heart muscle)
* Low [[blood pressure]] and dizziness from excessive urination (from medication)
* Increased sensitivity to [[digoxin]] with the potential for digoxin toxicity and related arrhythmias
* [[Ascites]] (fluid accumulation in the abdomen)
==Histopathological Findings==
[http://www.peir.net Images shown below are courtesy of Professor Peter Anderson and published with permission. © PEIR, University of Alabama at Birmingham, Department of Pathology]
<div align="left">
<gallery heights="175" widths="175">
image:LA Amyloid.jpg|Amyloidosis Lesion In Left Atrium: Gross natural color view of a diagnostic lesion
image:LA Amyloid 2.jpg|Amyloidosis Lesion In Left Atrium: Gross natural color close-up
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
image:Amyloidosis LA nodules.jpg|Amyloidosis, left atrium, endocardial nodules
image:Amyloidosis endocardial nodules.jpg|Amyloidosis, left atrium, endocardial nodules
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
image:Amyloidosis and LVH.jpg|Amyloidosis and left ventricular hypertrophy
image:Aldehyd Fuchsin.jpg|Heart: Amyloidosis, aldehyde fuchsin stain.
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
image:Amyloidosis Kongored.jpg|Heart: Perivascular amyloid, amyloidosis, congo red showing birefringence
image:Perivas Amyloid.jpg|Heart: Perivascular amyloid, amyloidosis (Hematoxylin and eosin staining)
</gallery>
</div>
===An Case Example===
====Clinical Summary====
This 87-year-old black male diabetic was admitted for amputation of the lower extremity involved by atherosclerotic gangrene and osteomyelitis. Following amputation, the patient's course was one of progressive deterioration. Laboratory studies immediately prior to death revealed a blood glucose of 840 mg/dL and a serum CO2 (bicarbonate) of 8.5 mmol/L.
====Autopsy Findings====
The heart weighed 540 grams. The endocardial surface of both atria presented a mottled gray-red and gray-white appearance. Multiple sections through the myocardium revealed a marked 'pallor' of the muscle.
====Images====
<div align="left">
<gallery heights="175" widths="175">
Image:Cardiac amyloidosis case 1.jpg|This is a gross photograph of section of heart tissue from this case. The tissue was firm and had a waxy texture. If you use your imagination you can see pale yellow areas within this tissue which represent the amyloid deposits.
Image:Cardiac amyloidosis case 2.jpg|This is a low power photomicrograph of the heart tissue from this case. At this magnification the structure looks relatively normal.
Image:Cardiac amyloidosis case 3.jpg|This is a higher-power photomicrograph of the heart tissue from this case. Note the amyloid deposition throughout the myocardium (1) as well as deposition in the wall of the blood vessel (2).
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:Cardiac amyloidosis case 4.jpg|This is a higher-power photomicrograph of extracellular amyloid (1) and deposition of amyloid in the vessel wall (2).
Image:Cardiac amyloidosis case 5.jpg|This is a special stain for amyloid (Luxol PAS) demonstrating the amyloid (1) and fibrosis (2) in the myocardium. The amyloid is darker purple/magenta and tends to be more amorphous. The fibrosis is pink and more fibrillar.
</gallery>
</div>
==References==
{{Reflist|2}}
==Additional Readings==
*Amyloid and amyloidosis. Gilles Grateau, Robert A. Kyle, Martha Skinner, 2005 ISBN 0-8493-3534-5
==External Resources==
*[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1163465 Amyloid Heart Disease]
*[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=481616 Primary cardiac amyloidosis in a young man presenting with angina pectoris]
*[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1146050 Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring]
*[http://eurheartj.oxfordjournals.org/cgi/content/full/27/15/1810 Obstructive intramural coronary amyloidosis: a distinct phenotype of cardiac amyloidosis that can cause acute heart failure]
*[http://www.cardiothoracicsurgery.org/content/1/1/38 Unique type of isolated cardiac valvular amyloidosis]
*[http://heart.bmj.com/cgi/content/full/88/1/90 Intracellular cardiac amyloidosis in familiar amyloid polyneuropathy of the Portuguese type]


{{Circulatory system pathology}}
{{Circulatory system pathology}}
{{Amyloidosis}}
{{Amyloidosis}}
{{SIB}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[CME Category::Cardiology]]


[[Category:Disease]]
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 20:18, 5 February 2020

Cardiac amyloidosis
Amyloidosis Lesion In Left Atrium: Gross natural color view of a diagnostic lesion
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

For patient information click here.
To go back to the Amyloidosis landing page, click here.

Cardiac amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac amyloidosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac amyloidosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac amyloidosis

CDC onCardiac amyloidosis

Cardiac amyloidosis in the news

Blogs on Cardiac amyloidosis

Directions to Hospitals Treating Cardiac amyloidosis

Risk calculators and risk factors for Cardiac amyloidosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2] Raviteja Guddeti, M.B.B.S. [3]; Cafer Zorkun, M.D., Ph.D. [4]; Lakshmi Gopalakrishnan, M.B.B.S. [5], Sabawoon Mirwais, M.B.B.S, M.D.[6]

Synonyms and keywords: Cardiac amyloid; amyloid cardiac; amyloid cardiomyopathy; stiff heart syndrome; senile cardiac amyloidosis; AS transthyretin amyloidosis; amyloid heart muscle disease; amyloid heart disease; amyloid heart; CA

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type (senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
Lysozyme amyloid related amyloidosis
Leucocyte cell-derived chemotaxin 2 related amyloidosis
Fibrinogen A alpha-chain associated amyloidosis

Pathophysiology

Causes

Differentiating Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac amyloidosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac amyloidosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac amyloidosis

CDC on Cardiac amyloidosis

Cardiac amyloidosis in the news

Blogs on Cardiac amyloidosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cardiac amyloidosis


Template:WikiDoc Sources CME Category::Cardiology